What question did this study set out to answer?

To synthesize the findings of late-breaking clinical trials presented at the European Congress of Cardiology regarding cardiovascular prevention, interventions, and pharmacotherapies.

November 12, 2004European Heart Journal

Hotline sessions of the 26th European Congress of Cardiology

View Full Paper

Ask AI

Bookmark

Design

Review

Authors

SSS L SchellekensRadboud University Nijmegen FVFreek W.A. VerheugtLeiden University

Discussion

Member takes

Implication

Hotline summaries span prevention, ACS, arrhythmias, and HF; leaves open practice impact pending full peer-reviewed data.

Key Points

To synthesize the findings of late-breaking clinical trials presented at the European Congress of Cardiology regarding cardiovascular prevention, interventions, and pharmacotherapies.
Assessed multiple multicenter, randomized controlled trials evaluating pharmacologic agents (nifedipine, rimonabant, prasugrel, dronedarone, nebivolol, cerivastatin, and antibiotics) and interventional strategies.
Populations included patients with stable angina, obesity, non-ST-elevation acute coronary syndromes, atrial fibrillation, and congestive heart failure across varied follow-up durations.
In RIO-EUROPE, rimonabant 20 mg achieved significant weight reduction (-6.6 kg vs. -1.8 kg for placebo, p<0.001), while SENIORS demonstrated reduced all-cause mortality or cardiovascular admission with nebivolol (31.1% vs. 35.3%, p=0.04).
In the ICTUS trial, an early invasive strategy showed no superiority over a selective invasive approach for the primary composite endpoint (21.7% vs. 20.4%, p=0.59), with higher recurrent myocardial infarction in the early invasive group (14.6% vs. 9.4%, p=0.006).
Antibiotic regimens in PROVE IT-TIMI 22 (gatifloxacin: 23.7% vs. placebo: 25.1%, p=0.41) and ACES (azithromycin: 22.3% vs. placebo: 22.4%, p=ns) showed no significant reduction in major cardiovascular events.

Cite This Study

Schellekens et al. (2004) studied this question.

synapsesocial.com/papers/6a72c1e9e5469ee92be28da7 https://doi.org/10.1016/j.ehj.2004.09.031

View Full Paper

Ask AI

Bookmark

Hotline sessions of the 26th European Congress of Cardiology

Discussion

Member takes

Implication

Key Points

Cite This Study

Hotline sessions of the 26th European Congress of Cardiology

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider